Hext Pharma Private Limited
About Hext Pharma Private Limited
Data last updated:
Hext Pharma Private Limited is a private limited company based in Delhi, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 19 April 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC396890.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rishabh and Munmun Kumari.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 27/109/3A Opp Shankar Gali Main Pandav Road Jwala Nagar Shahdara, Delhi, India – 110032.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.3 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹27,516 (net margin 1.2%) and EBITDA of ₹64,586 (EBITDA margin 2.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address27/109/3A Opp Shankar Gali Main Pandav Road Jwala Nagar Shahdara, Delhi, India – 110032
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hext Pharma Private Limited
The main business activity of Hext Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hext Pharma Private Limited FY 2025 filings available
Hext Pharma Private Limited reported revenue of ₹23.3 Lakh (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Hext Pharma Private Limited
Revenue rose 39% in the latest year. EBITDA rose 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Hext Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹64,586 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹27,516 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Hext Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.8% | •••• |
| Net Profit Margin | 1.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hext Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hext Pharma Private Limited
Hext Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medi Pharma Innovation Private Limited | ₹23.31 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Uvisun Organic Private Limited | ₹23.31 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Noida, Uttar Pradesh, India |
| Nikhilam Agri Genetics Private Limited | ₹23.31 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | Jaipur, Rajasthan, India |
| Triad Distributors India Private Limited | ₹23.31 Lakh (FY 2020) | •••• | •••• | •••• | North Twenty Four Pargana, West Bengal, India | |
| PRK Plywoods and Interior Materials Private Limited | ₹23.3 Lakh (FY 2019) | •••• | •••• | •••• | Kunnamkulam, Kerala, India | |
| Hext Pharma Private Limited this company | ₹23.3 Lakh (FY 2024) | •••• | •••• | 39.0% | •••• | Delhi, India |
| Maitreyee Chemical Industries Private Limited | ₹23.3 Lakh (FY 2024) | •••• | •••• | 29.0% | •••• | Bolpur, West Bengal, India |
| Thekkeindia Private Limited | ₹23.3 Lakh (FY 2022) | •••• | •••• | 26258.0% | •••• | Thane, Maharashtra, India |
| Masashi Tradeimpex Private Limited | ₹23.29 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Kottayam, Kerala, India |
| Sadananda Enterprises Private Limited | ₹23.29 Lakh (FY 2020) | •••• | •••• | 5.0% | •••• | Kolkata, West Bengal, India |
| Fabcon Lifesciences Private Limited | ₹23.29 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Hext Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Hext Pharma Private Limited
Hext Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh | Director | 22 Jan 2024 | 2 Years 8 Months | Current |
| Munmun Kumari | Director | 19 Apr 2022 | 4 Years 5 Months | Current |
Charges & Borrowings of Hext Pharma Private Limited
Hext Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hext Pharma Private Limited
Employment history and EPFO contributions of people linked to Hext Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hext Pharma Private Limited
Hext Pharma Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Bipin Kumar Singh ceased to be Director on 22 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Hext Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hext Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hext Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hext Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hext Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hext Pharma Private Limited
Hext Pharma is an active private limited company based in Delhi, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 19 April 2022 (4+ years old) and is registered under CIN U24290DL2022PTC396890.
Hext Pharma reported revenue of ₹23.3 Lakh for FY 2024 (up 39% YoY).
Hext Pharma has 2 current directors:
- Rishabh - Director
- Munmun Kumari - Director
Hext Pharma reported a net profit of ₹27,516 (net margin 1.2%) and EBITDA of ₹64,586 (EBITDA margin 2.8%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Hext Pharma is U24290DL2022PTC396890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hext Pharma was incorporated on 19 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Hext Pharma by revenue are Medi Pharma Innovation Private Limited, Uvisun Organic Private Limited, Nikhilam Agri Genetics Private Limited, Triad Distributors India Private Limited, PRK Plywoods and Interior Materials Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Bipin Kumar Singh ceased to be Director on 22 Jan 2024. Rishabh was appointed as Director on 22 Jan 2024. Munmun Kumari was appointed as Director on 19 Apr 2022.
The registered office of Hext Pharma is at 271093A Opp Shankar Gali Main Pandav Road Jwala Nagar Shahdara, Delhi, India – 110032.
Hext Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.
Hext Pharma operates in the chemicals industry, in the other chemical product segment.